The increased formation and accumulation of advanced glycation endproducts (AGEs) in arthritis and a link to the decreased metabolism of glyoxal and MG with decreased glyoxalase 1 (Glo1) [26]—which is involved in the main pathway for the metabolism of these reactive dicarbonyl metabolites—have long been suspected. The gene discussed is GLO1; the disease is arthritic joint disease.